In vitro studies have shown that treatment with propranolol, β3-AR antagonist L-748337 or β3-AR siRNAs reduces proliferation and induces apoptosis of human and mouse melanoma cells [5,20,21], whereas β3-AR stimulation with BRL37344 promotes melanoma cell proliferation and reduces apoptosis [22]. Here, ADRB3 is linked to melanoma.